| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10571-016-0430-8 |
| P698 | PubMed publication ID | 27709309 |
| P2093 | author name string | Feng Zhang | |
| Bin Zhang | |||
| Ning Yang | |||
| Shao-Peng Lin | |||
| P2860 | cites work | Prognostic significance of uric acid serum concentration in patients with acute ischemic stroke | Q28192706 |
| Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and against focal ischemic brain injury in vivo | Q32027902 | ||
| Is elevated SUA associated with a worse outcome in young Chinese patients with acute cerebral ischemic stroke? | Q33694991 | ||
| Uric acid administration in patients with acute stroke: a novel approach to neuroprotection | Q37083643 | ||
| Injury and repair mechanisms in ischemic stroke: considerations for the development of novel neurotherapeutics. | Q37541913 | ||
| NADPH oxidases as therapeutic targets in ischemic stroke. | Q38012354 | ||
| Serum Uric Acid Levels and Outcomes After Acute Ischemic Stroke | Q38368304 | ||
| The role of uric acid as a potential neuroprotectant in acute ischemic stroke: a review of literature | Q38378478 | ||
| Uric Acid Therapy Improves Clinical Outcome in Women With Acute Ischemic Stroke. | Q38408321 | ||
| National stroke registries for monitoring and improving the quality of hospital care: A systematic review | Q38695414 | ||
| High levels of serum uric acid are associated with silent brain infarction | Q39851651 | ||
| Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke. | Q40576886 | ||
| Serum uric acid is neuroprotective in Chinese patients with acute ischemic stroke treated with intravenous recombinant tissue plasminogen activator | Q41147676 | ||
| The URICO-ICTUS study, a phase 3 study of combined treatment with uric acid and rtPA administered intravenously in acute ischaemic stroke patients within the first 4.5 h of onset of symptoms. | Q42968240 | ||
| Is uric acid protective or deleterious in acute ischemic stroke? A prospective cohort study | Q43275781 | ||
| Decreased uric acid levels correlate with poor outcomes in acute ischemic stroke patients, but not in cerebral hemorrhage patients | Q43917486 | ||
| Dose-response relationship of serum uric acid levels with risk of stroke mortality | Q44846535 | ||
| Uric acid-driven Th17 differentiation requires inflammasome-derived IL-1 and IL-18. | Q46158395 | ||
| Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system | Q46809905 | ||
| Course of matrix metalloproteinase-9 isoforms after the administration of uric acid in patients with acute stroke: a proof-of-concept study | Q47794204 | ||
| A pilot study of dual treatment with recombinant tissue plasminogen activator and uric acid in acute ischemic stroke | Q48156395 | ||
| Uric acid improves glucose-driven oxidative stress in human ischemic stroke | Q48357007 | ||
| Decrease in uric acid in acute ischemic stroke correlates with stroke severity, evolution and outcome | Q48374884 | ||
| Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke | Q48593375 | ||
| Serum uric acid and risk of ischemic stroke: the ARIC Study | Q48722176 | ||
| Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised, double-blind phase 2b/3 trial. | Q50702011 | ||
| Uric Acid Levels Are Relevant in Patients With Stroke Treated With Thrombolysis | Q63385154 | ||
| Soluble uric acid primes TLR-induced proinflammatory cytokine production by human primary cells via inhibition of IL-1Ra | Q86653435 | ||
| P433 | issue | 5 | |
| P921 | main subject | cerebral infarction | Q1209150 |
| reperfusion injury | Q1413991 | ||
| P304 | page(s) | 931-939 | |
| P577 | publication date | 2016-10-05 | |
| P1433 | published in | Cellular and Molecular Neurobiology | Q2333197 |
| P1476 | title | Suitable Concentrations of Uric Acid Can Reduce Cell Death in Models of OGD and Cerebral Ischemia-Reperfusion Injury | |
| P478 | volume | 37 |
| Q57159631 | A new era for stroke therapy: Integrating neurovascular protection with optimal reperfusion |
| Q47188375 | Evaluation of efficacy and safety of Reteplase and Alteplase in the treatment of hyper-acute cerebral infarction |
| Q92243841 | Serum Uric Acid and Triglycerides in Chinese Patients with Newly Diagnosed Moyamoya Disease: A Cross-Sectional Study |
| Q89871246 | The protective effect of uric acid in reducing TLR4/NF-κB activation through the inhibition of HMGB1 acetylation in a model of ischemia-reperfusion injury in vitro |
| Q52746389 | Uric acid promotes oxidative stress and enhances vascular endothelial cell apoptosis in rats with middle cerebral artery occlusion. |
Search more.